anmelden
SPI
20.149,63
PKT
+38,43
PKT
+0,19
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 10.12.12 | Helvetia Baloise buy | Nomura | |
| 10.12.12 | METALL ZUG hold | Vontobel Research | |
| 10.12.12 | Schweiter hold | Vontobel Research | |
| 10.12.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 10.12.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 10.12.12 | ARYZTA neutral | Sarasin Research | |
| 07.12.12 | Clariant hold | Deutsche Bank AG | |
| 07.12.12 | Givaudan sell | Deutsche Bank AG | |
| 07.12.12 | BELIMO hold | Vontobel Research | |
| 07.12.12 | Bucher Industries hold | Vontobel Research | |
| 06.12.12 | Nestlé hold | Deutsche Bank AG | |
| 06.12.12 | Orascom Development neutral | Sarasin Research | |
| 05.12.12 | Roche overweight | J.P. Morgan Cazenove | |
| 05.12.12 | UBS buy | Deutsche Bank AG | |
| 05.12.12 | Implenia buy | Vontobel Research | |
| 05.12.12 | Richemont hold | Vontobel Research | |
| 04.12.12 | OC Oerlikon buy | UBS AG | |
| 04.12.12 | Swiss Re buy | Société Générale Group S.A. (SG) | |
| 04.12.12 | Swiss Prime Site hold | Vontobel Research | |
| 04.12.12 | Sonova overweight | Morgan Stanley | |
| 04.12.12 | Richemont hold | Renaissance Capital | |
| 04.12.12 | Julius Bär reduce | Vontobel Research | |
| 04.12.12 | OC Oerlikon buy | Vontobel Research | |
| 03.12.12 | ARYZTA hold | Vontobel Research | |
| 03.12.12 | Nestlé hold | Vontobel Research | |
| 03.12.12 | Kühne + Nagel International hold | Vontobel Research | |
| 03.12.12 | Galenica reduce | Vontobel Research | |
| 03.12.12 | Zurich Insurance buy | Nomura | |
| 03.12.12 | ARYZTA neutral | Sarasin Research | |
| 03.12.12 | Nestlé overweight | Morgan Stanley | |
| 03.12.12 | Swatch (I) buy | Goldman Sachs Group Inc. | |
| 03.12.12 | Clariant underperform | Credit Suisse Group | |
| 30.11.12 | ABB (Asea Brown Boveri) neutral | HSBC | |
| 30.11.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 30.11.12 | UBS outperform | Exane-BNP Paribas SA | |
| 30.11.12 | ARYZTA hold | Société Générale Group S.A. (SG) | |
| 30.11.12 | Roche buy | Sarasin Research | |
| 30.11.12 | Holcim hold | Société Générale Group S.A. (SG) | |
| 30.11.12 | Holcim overweight | Morgan Stanley | |
| 30.11.12 | Holcim equal-weight | Morgan Stanley |
